News
Resources
Blog
Sites
Ensuring global vaccine equity requires eliminating trade and regulatory barriers
By Megan Van Etten | August 5, 2021
The following is part of a series of Catalyst posts detailing each of the five strategies to advance COVID-19 global vaccine equity – which rely on and benefit from a strong innovation ecosystem.
Read More
Setting the record straight: Addressing common misconceptions about the COVID-19 vaccine
By Mike Ybarra | August 4, 2021
Bolstered by incredible progress in the fight against COVID-19, the biopharmaceutical industry continues to work around the clock to research, develop and manufacture vaccines and therapeutics to...
Read More
Increasing global access to vaccines by optimizing production
By Megan Van Etten | July 29, 2021
The following is part of a series of posts detailing each of the five strategies to advance global COVID-19 vaccine equity – which rely on and benefit from a strong intellectual property ecosystem.
Read More
Guest post: Retired medics return to the field to take on vaccine delivery and disaster relief
By Guest Contributor | July 23, 2021
Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today’s challenges and opportunities. The PhRMA blog welcomes guest...
Read More
Guest Post: A patient’s story of the long-term health impacts of COVID-19
By Guest Contributor | July 21, 2021
Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today’s challenges and opportunities. The PhRMA blog welcomes guest...
Read More
Dose sharing as a part of the COVID-19 global vaccine equity strategy
By Megan Van Etten | July 20, 2021
The following is part of a series of Catalyst posts detailing each of the five strategies to advance COVID-19 global vaccine equity – which rely on and benefit from a strong innovation ecosystem.
Read More
Promoting global vaccine equity while protecting innovation
By Megan Van Etten | July 15, 2021
America’s biopharmaceutical companies have successfully researched, developed and distributed billions of doses of multiple vaccines and therapeutics to halt the spread of COVID-19. The...
Read More
Data shows COVID-19 vaccines are creating a pathway to a strong U.S. recovery
By Tom Wilbur | July 2, 2021
As we head into the Fourth of July weekend, Americans are reemerging from the COVID-19 pandemic with heightened hopes and confidence in a strong U.S. recovery. The COVID-19 vaccines have been...
Read More
By
As part of PhRMA’s continuing commitment to build a more just and equitable health care system, we recently awarded $75,000 through our Collaborative Actions to Reach Equity (CAREs) grant program...
Read More
More than 800 medicines are in development for diseases that disproportionately affect racial and ethnic communities
By Andrew Powaleny | June 22, 2021
We are in a new era of medicine where groundbreaking biopharmaceutical research and development is transforming medicine, but these innovations are meaningless if they don’t reach patients,...
Read More
Medicare Monday (100)
340B Spotlight (46)
Cost & Consequence (0)
